New plan for insulin reimbursement concerns Danish diabetes association

Diabetes patient association Diabetesforeningen is unhappy with the proposed changes to the insulin reimbursement scheme, which it sees as a cost-cutting exercise that fails to take patients into consideration.

Jens Dresling/Ritzau Scanpix | Photo: Jens Dresling/Ritzau Scanpix

A proposal for changes to the reimbursement program for diabetes medicine has not been well-received by patient association Diabetesforeningen.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs